Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

Marino Cimitan; Laura Evangelista; Marina Hodolič; Giuliano Mariani; Tanja Baseric; Valentina Bodanza; Giorgio Saladini; Duccio Volterrani; Anna Rita Cervino; Michele Gregianin; Giulia Puccini; Federica Guidoccio; Jure Fettich; Eugenio Borsatti

doi:10.2967/jnumed.114.141887

Research ArticleClinical Investigations

Gleason Score at Diagnosis Predicts the Rate of Detection of ¹⁸F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

Marino Cimitan, Laura Evangelista, Marina Hodolič, Giuliano Mariani, Tanja Baseric, Valentina Bodanza, Giorgio Saladini, Duccio Volterrani, Anna Rita Cervino, Michele Gregianin, Giulia Puccini, Federica Guidoccio, Jure Fettich and Eugenio Borsatti

Journal of Nuclear Medicine February 2015, 56 (2) 209-215; DOI: https://doi.org/10.2967/jnumed.114.141887

Marino Cimitan

1Nuclear Medicine Unit, IRCCS National Cancer Institute (CRO), Aviano, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Laura Evangelista

2Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology, IRCCS, Padua, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marina Hodolič

3Nuclear Medicine Department, University Medical Center Ljubljana, Ljubljana, Slovenia; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giuliano Mariani

4Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tanja Baseric

1Nuclear Medicine Unit, IRCCS National Cancer Institute (CRO), Aviano, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Valentina Bodanza

1Nuclear Medicine Unit, IRCCS National Cancer Institute (CRO), Aviano, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giorgio Saladini

2Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology, IRCCS, Padua, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Duccio Volterrani

4Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Rita Cervino

2Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology, IRCCS, Padua, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michele Gregianin

2Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology, IRCCS, Padua, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giulia Puccini

4Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Federica Guidoccio

4Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jure Fettich

3Nuclear Medicine Department, University Medical Center Ljubljana, Ljubljana, Slovenia; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eugenio Borsatti

1Nuclear Medicine Unit, IRCCS National Cancer Institute (CRO), Aviano, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 56, Issue 2

February 1, 2015

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Gleason Score at Diagnosis Predicts the Rate of Detection of ¹⁸F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

Journal of Nuclear Medicine Feb 2015, 56 (2) 209-215; DOI: 10.2967/jnumed.114.141887

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Gleason Score at Diagnosis Predicts the Rate of Detection of ¹⁸F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

Journal of Nuclear Medicine Feb 2015, 56 (2) 209-215; DOI: 10.2967/jnumed.114.141887

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Molecular Imaging of Prostate Cancer: Tapping into the Opportunities
This Month in JNM
Erratum

PubMed
Google Scholar

Cited By...

11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
Molecular Imaging of Prostate Cancer: Tapping into the Opportunities

Google Scholar

Keywords

18F-choline PET
Gleason score
prostate cancer
PSA
Restaging

Main menu

User menu

Search

Gleason Score at Diagnosis Predicts the Rate of Detection of ¹⁸F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords